Max Robotics — Global Service Robot Directory + US Certification

About

Yuki Sekido is a colorectal surgeon and researcher whose work focuses on advancing treatment strategies for rectal cancer and improving surgical safety. Her primary research areas include neoadjuvant therapy for locally advanced rectal cancer (LARC) and the prevention of rare but serious surgical complications. In her most cited paper (2022, 11 citations), she explored the use of total neoadjuvant therapy combined with nivolumab for LARC—a novel immunotherapy-based approach that challenges standard chemoradiotherapy protocols and offers a potential pathway to organ preservation. Her second notable study (2024, 2 citations) investigates risk factors for elevated creatine kinase levels as an early indicator of well-leg compartment syndrome following laparoscopic or robot-assisted colorectal surgery in the lithotomy-Trendelenburg position. This work addresses a critical patient safety concern, aiming to prevent severe complications through better intraoperative monitoring. While her citation counts are still growing, Sekido’s contributions are significant for their clinical relevance and forward-looking integration of immunotherapy into standard oncologic care. Her research is particularly valuable for surgeons and oncologists seeking to optimize both oncologic outcomes and patient safety in colorectal surgery.